Article Information
History
- September 18, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Valentina Mazzotta1,
- Pierluca Piselli2,*,
- Alessandro Cozzi Lepri3,
- Giulia Matusali4,
- Eleonora Cimini5,
- Rozenn Esvan1,
- Francesca Colavita4,
- Roberta Gagliardini1,
- Stefania Notari5,
- Alessandra Oliva1,
- Silvia Meschi4,
- Rita Casetti5,
- Giulia Micheli1,
- Licia Bordi4,
- Alessandro Giacinta1,
- Germana Grassi5,
- Saba Gebremeskel Tekle1,
- Claudia Cimaglia2,
- Jessica Paulicelli1,
- Alessandro Caioli2,
- Paola Gallì6,
- Giulia Del Duca1,
- Miriam Lichtner7,
- Loredana Sarmati8,
- Enrica Tamburrini9,10,
- Claudio Mastroianni11,
- Alessandra Latini12,
- Paolo Faccendini13,
- Carla Fontana14,
- Emauele Nicastri1,
- Andrea Siddu15,
- Alessandra Barca16,
- Francesco Vaia15,
- Enrico Girardi17,
- Fabrizio Maggi4,
- Andrea Antinori1,
- MPOX Vaccine Lazio Study Group
- 1Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
- 2Clinical Epidemiology Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
- 3Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, UCL, London, UK
- 4Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
- 5Cellular Immunology and Pharmacology Laboratory, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy
- 6Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
- 7Infectious Diseases Unit, Santa Maria Goretti Hospital of Latina, NESMOS Department, Sapienza University of Rome, Italy
- 8Infectious Diseases Unit, Tor Vergata University Hospital, Rome, Italy
- 9Department of Safety and Bioethics, Catholic University of the Sacred Heart, Rome, Italy
- 10Infectious Diseases Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- 11Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy
- 12STI/HIV Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy
- 13Pharmacy Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
- 14Laboratory of Microbiology and Biological Bank Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
- 15General Directorate of Prevention, Ministry of Health, Rome, Italy
- 16Unit of Health Promotion and Prevention, Directorate of Health and Integration, Lazio Region, Rome, Italy
- 17Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
- ↵*Corresponding author
Pierluca Piselli, MSc MPH, E-mail: pierluca.piselli{at}inmi.it Clinical Epidemiology Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS Via Portuense 292, 00149 Rome, Italy
Posted September 18, 2024.
Reactogenicity and immunogenicity against MPXV of the intradermal administration of Modified Vaccinia Ankara compared to the standard subcutaneous route
